Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Gutovich Jeffrey — CB Pharma Acquisition Corp. insider: 2 transactions · InsiderLens

Home / Insiders / Gutovich Jeffrey

Gutovich Jeffrey

Director at CB Pharma Acquisition Corp. · on record since Jun 23, 2016

Insider trading activity of Gutovich Jeffrey

Transactions on record: 2; since Jun 14, 2016

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 23, 2016

Figures computed from official regulatory filings — methodology.

Companies where Gutovich Jeffrey has traded

CB Pharma Acquisition Corp.2 tx · Jun 23, 2016

Track record of Gutovich Jeffrey

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Gutovich Jeffrey

Co-insiders of Gutovich Jeffrey

Aldeanueva JoseCB Pharma Acquisition Corp.
Avgerinos GeorgeCB Pharma Acquisition Corp.
Chill Adam J.CB Pharma Acquisition Corp.
CORONADO BIOSCIENCES INCCB Pharma Acquisition Corp.
FRED EDWARD JCB Pharma Acquisition Corp.
Herskowitz NeilCB Pharma Acquisition Corp.
KORNBLUTH ARTHUR ASHERCB Pharma Acquisition Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

North Pole Capital Master FundCB Pharma Acquisition Corp.

Polar Securities Inc.CB Pharma Acquisition Corp.

Pudles StephenCB Pharma Acquisition Corp.

RODGERS BARRYCB Pharma Acquisition Corp.

ROSENWALD LINDSAY A MDCB Pharma Acquisition Corp.

WEISS MICHAEL SCB Pharma Acquisition Corp.

Company	Filed	Type	Qty	Price	Value · USD	Src
CB Pharma Acquisition Corp.	Jun 23, 2016	Other	4,333	—	—	SEC
CB Pharma Acquisition Corp.	Jun 14, 2016	AwardD	2,187	—	—	SEC